Clinical Trials Logo
  1. Home
  2. Transplant; Failure, Heart
  3. NCT03079791

Impact of Level and Quality of Immunosuppression on Onset and Pattern of Cardiac Allograft Vasculopathy Evaluated by OCT — IMPROVE-OCT  

Transplant; Failure, Heart Clinical Trial

Official title:
Prospective Registry of Impact of Level and Quality of Immunosuppression on Onset and Pattern of Cardiac Allograft Vasculopathy Evaluated by OCT.

Clinical Trial Summary

The aim of this study is to use the high resolution of optical coherence tomography to assess the prevalence of different types of cardiac allograft vasculopathy (CAV) in cardiac transplanted patients and correlate those results with the level of immunosuppression

Clinical Trial Description

CAV is the most common reason for retransplantation at >1 year and one of the main risk factors for mortality after cardiac transplantation. For this registry, patients planned to undergo coronary angiography either as a part of routine follow-up to screen for relevant cardiac allograft vasculopathy or because of clinical suspicion of relevant cardiac allograft vasculopathy will be considered eligible. Since the "Transplant Care Guidelines of 2010" recommend the use of intracoronary imaging during angiographic follow-up in patients after heart transplantation to recognize CAV as early as possible, OCT has become integral part of the CAV diagnostic in our center. Through its high resolution OCT (so called virtual histology) provides the earliest possible diagnosis of CAV as well as new insights into the differentiation of CAV types. We aim to correlate the findings of OCT with the level of immunosuppression. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03079791
Study type Observational [Patient Registry]
Source LMU Klinikum
Contact
Status Completed
Phase
Start date July 2016
Completion date January 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04493385 - The Hepatitis C Transplant Collaborative
Recruiting NCT05881278 - XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS) N/A
Enrolling by invitation NCT06147271 - Impact of SGLT2 Inhibitors in Heart Transplant Recipients Phase 2
Recruiting NCT05610787 - EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study N/A
Recruiting NCT04656080 - Cardiopulmonary Stress Testing (CPET) AlloSure Study
Completed NCT04493346 - Shear Wave Elastography
Not yet recruiting NCT06396702 - EASE-SOT Pilot Study N/A
Completed NCT05212649 - Optimized Peak VO2 in Predicting Advanced HF
Completed NCT03150147 - A Randomized Controlled Trial Comparing Non-ischemic to Ischemic Preservation in Adult Cardiac Transplantation N/A
Enrolling by invitation NCT04066127 - Non-ischaemic Heart Preservation Versus Standard Cold Storage in Human Heart Transplantation N/A
Not yet recruiting NCT04146727 - Utilizing Technology for Optimization of Pain Management and Mobilization in High Risk Cardiac Surgical ICU Patients
Recruiting NCT03506737 - Exercise-based Cardiac Rehabilitation Program on Hospitalized Heart Failure Patients Submitted to Cardiac Transplantation N/A
Completed NCT06026215 - Assessing the Effects of Mechanical Unloading on Repair Version-1
Recruiting NCT05034354 - Virtual Remote Physiological Monitoring Program of Children With Heart Disease N/A
Recruiting NCT05451979 - HIIT in Pediatric Heart Transplant Recipients (MedBIKE™) N/A
Active, not recruiting NCT03575910 - HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection